发明人马晓峰,韩伟,王建平. "Method for the Synthesis of N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide" [P]. 中国发明专利, 专利号 CN 114725644 A, 授权公告日 2015-07-11.
发明人王建平,钱学锋,马晓峰. "A Process for Preparing High-Purity N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide" [P]. 中国发明专利, 专利号 CN 108481482 A, 授权公告日 2019-08-16.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of Zibotentan (ZD4054) in Pharmaceutical Formulations". J. Chromatogr. A, 2018, 1966, (1), 9333-9357.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of Zibotentan (ZD4054) as an Impurity". Biomed. Chromatogr., 2011, 1821, (11), 5804-5807.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide Using HRMS and NMR". Anal. Chim. Acta, 2017, 1517, 4976-4991.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Zibotentan (ZD4054) Profile in Drug Substances According to ICH Guidelines". Food Chem., 2020, 210, 9438-9444.